CUSIP 218352102 · who reports it, how much, and how much it matters to them
24 of the 720 hedge fund managers we track reported shares of Corcept Therapeutics Inc (Nasdaq: CORT) on Form 13F for 30 June 2026. Between them they reported USD 735m. The largest position belongs to Renaissance Technologies, at USD 457m. The manager with the most riding on it is Boxer Capital Management, where it is 2.2% of the reported book.
Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated
Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.
A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.
Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.
The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Renaissance Technologies13 funds on PPLI.com | USD 457m | 0.6% |
| 2 | D. E. Shaw & Co.15 funds on PPLI.com | USD 77m | 0.0% |
| 3 | Two Sigma Investments35 funds on PPLI.com | USD 53m | 0.0% |
| 4 | Perceptive Advisors6 funds on PPLI.com | USD 35m | 0.5% |
| 5 | Boxer Capital Management1 fund on PPLI.com | USD 29m | 2.2% |
| 6 | Capital Fund Management S.A.12 funds on PPLI.com | USD 16m | 0.1% |
| 7 | Millennium Management6 funds on PPLI.com | USD 13m | 0.0% |
| 8 | Citadel Advisors32 funds on PPLI.com | USD 9.5m | 0.0% |
| 9 | Walleye Capital8 funds on PPLI.com | USD 8.7m | 0.0% |
| 10 | O'Neil Global Advisors6 funds on PPLI.com | USD 8.6m | 1.9% |
| 11 | Voleon Capital Management13 funds on PPLI.com | USD 8m | 0.1% |
| 12 | Rock Springs Capital Management2 funds on PPLI.com | USD 6.3m | 0.3% |
| 13 | Bridgewater Associates45 funds on PPLI.com | USD 5m | 0.0% |
| 14 | Dark Forest Capital Management2 funds on PPLI.com | USD 2.5m | 0.2% |
| 15 | Balyasny Asset Management25 funds on PPLI.com | USD 2.2m | 0.0% |
| 16 | Lighthouse Investment Partners190 funds on PPLI.com | USD 1.4m | 0.0% |
| 17 | Marshall Wace LLP84 funds on PPLI.com | USD 489,000 | 0.0% |
| 18 | Squarepoint Ops7 funds on PPLI.com | USD 397,000 | 0.0% |
| 19 | Engineers Gate Manager1 fund on PPLI.com | USD 320,000 | 0.0% |
| 20 | CIBC Asset Management69 funds on PPLI.com | USD 286,000 | 0.0% |
| 21 | Mirabella Financial Services LLP10 funds on PPLI.com | USD 262,000 | 0.0% |
| 22 | Capstone Investment Advisors25 funds on PPLI.com | USD 237,000 | 0.0% |
| 23 | Freestone Grove Partners1 fund on PPLI.com | USD 86,515 | 0.0% |
| 24 | Fulcrum Asset Management LLP7 funds on PPLI.com | USD 8,086 | 0.0% |
A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.
| # | Manager | Value reported | Share of its book |
|---|---|---|---|
| 1 | Boxer Capital Management | USD 29m | 2.2% |
| 2 | O'Neil Global Advisors | USD 8.6m | 1.9% |
| 3 | Renaissance Technologies | USD 457m | 0.6% |
| 4 | Perceptive Advisors | USD 35m | 0.5% |
| 5 | Rock Springs Capital Management | USD 6.3m | 0.3% |
| 6 | Dark Forest Capital Management | USD 2.5m | 0.2% |
| 7 | Voleon Capital Management | USD 8m | 0.1% |
| 8 | Capital Fund Management S.A. | USD 16m | 0.1% |
| 9 | Two Sigma Investments | USD 53m | 0.0% |
| 10 | Lighthouse Investment Partners | USD 1.4m | 0.0% |
Corcept Therapeutics Inc trades under the symbol CORT on the Nasdaq. Its CUSIP, the code used on Form 13F, is 218352102.
24 of the 720 hedge fund managers PPLI.com tracks reported Corcept Therapeutics Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Renaissance Technologies (USD 457m), D. E. Shaw & Co. (USD 77m), Two Sigma Investments (USD 53m), Perceptive Advisors (USD 35m) and Boxer Capital Management (USD 29m).
24 managers in our coverage reported it, and between them they run 615 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.
Boxer Capital Management, where the position was 2.2% of the reported 13F book at 30 June 2026.
No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.
Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Corcept Therapeutics Inc or with the managers listed.
Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.
Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.